Type 1 Diabetes Trial, Recruiting NCT05145374 Sponsor: University of Illinois at Chicago Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Type 1 Diabetes Trial, Recruiting

NCT05145374
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People (men and women) who have been diagnosed with Type 1 Diabetes
  • People who use an insulin pump to manage their diabetes

Who may not be able to join:

  • People who have been hospitalised for diabetes-related problems (such as dangerously high or low blood sugar episodes) in the past three months
  • People with serious heart or blood vessel problems, such as severe circulation issues in the legs, a history of heart attack, heart failure, blood clots, unstable chest pain, uncontrolled high blood pressure, or an abnormal resting heart tracing (EKG)
  • People whose exercise stress test showed significant heart rhythm problems, irregular heartbeats, electrical conduction issues in the heart, or signs of reduced blood flow to the heart during exercise
  • People with serious complications affecting the eyes (such as vision-threatening retinal disease) or the kidneys
  • People with any uncontrolled health condition (not related to muscles or joints) that would make it difficult to take part in an exercise program — for example, severe lung disease
  • People with muscle, joint, nerve, or bone conditions that affect the strength or movement of the legs — for example, a history of stroke or loss of feeling in the feet
  • People who are pregnant
  • People whose doctor has determined that exercise would be medically unsafe for them

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ali Cinar, Illinois Institute of Technology

Phone: 3127716497

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Illinois at Chicago
Registry
ClinicalTrials.gov
Start date
1 July 2022
Est. completion
15 July 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Measurement of Glucose Concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov